Fierce ObamaCare Critic Joins Trump Administration In Top Health-Care Role

Paul Mango, a former Pennsylvania gubernatorial candidate who is a fierce critic of ObamaCare, will join the Trump administration in a top health-care role.

Read More

US Judge Throws Out Suit Over Health Subsidy Cuts

A U.S. judge in San Francisco has thrown out a lawsuit over the Trump administration's decision to cut Affordable Care Act subsidies.

Read More

Democrats Wrestle With Election-Year Message On Health Care

Ringed by a handful of cheering activist supporters, liberal House Democrats gathered outside the Capitol this week to announce they were forming a caucus to seek “Medicare for All” — shorthand for government-financed health care.

Read More

Small Hikes Likely for Nevada Health Insurance Plans in 2019

Nevada’s health insurance rates will increase only slightly in 2019, the state’s Division of Insurance announced Tuesday.

Read More

Health Exchange Faces Additional Uncertainty After Trump Administration Announces Halt to Risk Adjustment Payments

Nevada’s health insurance exchange was injected with yet another dose of uncertainty over the weekend after the Trump administration announced it was stopping payments to insurance companies required under the Affordable Care Act to even out the burden of providing coverage to the sickest patients.

Read More

Nevada May Save Millions with Switch to State-Based Program

Nevada’s health insurance marketplace, the Silver State Health Insurance Exchange, is one step closer to transitioning onto a state-based operation.

Read More

Clark County School Support Staff Bemoan Health Insurance Cost Hike

Support staffers in the Clark County School District are lamenting an increase in health insurance costs, saying that higher out-of-pocket costs will leave them financially strapped.

Read More

Patient, Provider Groups Urge CMS to Reinstate Risk Adjustment Payments

Some of the nation's largest hospital and provider groups are speaking out against the Trump administration's decision to freeze risk adjustment payments.

Read More

FDA Targets Price-Gouging Drugmakers With Plan To Import Rival Products

If you’re an off-patent drug sitting pretty with no rivals—generic or otherwise—enjoy it while you can. To stir up competition, FDA is looking at importing drugs that are approved in other countries but not yet in the U.S.

Read More

FDA Plans to Ease OTC Approvals for Some Prescription Drugs

U.S. regulators proposed new guidelines Tuesday to make it easier for some common medicines to be sold without a prescription — and more convenient for consumers to get them.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square